Eli Lilly Total Non-Operating Income/Expense 2010-2025 | LLY

Eli Lilly total non-operating income/expense for the twelve months ending March 31, 2025 was $-0.485B, a 650.17% decline year-over-year.

  • Eli Lilly annual total non-operating income/expense for 2024 was $-0.219B, a 326.06% decline from 2023.
  • Eli Lilly annual total non-operating income/expense for 2023 was $0.097B, a 130.13% decline from 2022.
  • Eli Lilly annual total non-operating income/expense for 2022 was $-0.321B, a 59.18% increase from 2021.

Eli Lilly Total Non-Operating Income/Expense 2010-2025 | LLY

  • Eli Lilly annual total non-operating income/expense for 2024 was $-0.219B, a 326.06% decline from 2023.
  • Eli Lilly annual total non-operating income/expense for 2023 was $0.097B, a 130.13% decline from 2022.
  • Eli Lilly annual total non-operating income/expense for 2022 was $-0.321B, a 59.18% increase from 2021.